Researchers have demonstrated that inebilizumab reduced the risk of symptoms by 87 percent in patients with the rare affliction known as immunoglobulin G4-related disease (IgG4-RD).

If you are wondering how inflammation ages you, read on to learn how inflammaging may occur, plus tips to combat this natural ...